DROPERIDOL INJECTION DIN 02232449
Status: Cancelled Post Market
Holder: NOVOPHARM LIMITED
Health Canada record
| Active ingredient(s) | DROPERIDOL 2.5 MG |
|---|
| Dosage form | Liquid |
|---|
| Route | Intravenous; Intramuscular |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | N05AD08 DROPERIDOL |
|---|
| Original market date | 20-Apr-1998 |
|---|
| Current status date | 14-Mar-2002 |
|---|
| Source | Health Canada DPD |
|---|
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DROPERIDOL
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02167832 | DROPERIDOL INJECTION USP 2.5MG/ML | SANDOZ CANADA INCORPORATED | Solution | DROPERIDOL 2.5 MG | Cancelled Post Market |
| 00554251 | INAPSINE INJ 2.5MG/ML | JANSSEN PHARMACEUTICA, DIVISION OF JANSSEN-ORTHO INC. | Liquid | DROPERIDOL 2.5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 3755 | 1997-08-18 | Abbreviated New Drug Submission (ANDS) | |
International API supply for DROPERIDOL
1 valid EDQM Certificates of Suitability from 1 holders. 2 active FDA Drug Master Files.
Request a quote for DROPERIDOL INJECTION
How to read a Canadian DIN record